Written by Blood Plasma Derivatives Market Growth is being driven by increasing demand for immunoglobulins, the rising prevalence of chronic and immune-related disorders, and advances in plasma collection technologies. According to the latest MRFR assessment, the market is projected to grow from USD 46.6 billion in 2025 to USD 86.67 billion by 2035 at a CAGR of 6.47%. This expansion reflects the continuing clinical importance of plasma-derived therapies across multiple disease areas.
Immunoglobulin demand is an important contributor to market expansion, particularly as diagnosis and treatment of immunodeficiency and autoimmune disorders increase. Growing awareness of rare diseases is also supporting demand for specialized plasma products, including coagulation factors and albumin. At the same time, advances in automated plasma collection and separation techniques are helping strengthen supply capabilities and improve processing efficiency.
Emerging economies provide additional growth opportunities as healthcare expenditure, diagnostic capabilities, and access to specialized treatments improve. Investments in plasma collection centers and automated processing infrastructure can help address supply requirements while supporting wider availability of therapies. Continued research into new therapeutic applications of plasma-derived products is expected to create further opportunities for manufacturers throughout the forecast period.
Strengthen your strategy with data-backed research insights:
Genetic Engineering Market Size
Genetic Engineering Market Share
Health Information Exchange Market Trends